— Know what they know.
Not Investment Advice

IRON NASDAQ

Disc Medicine, Inc.
1W: -1.1% 1M: -19.4% 3M: -16.2% YTD: -18.4% 1Y: -3.8% 3Y: +33.1% 5Y: +48.3%
$64.51
+0.90 (+1.41%)
 
Weekly Expected Move ±4.4%
$59 $62 $65 $67 $70
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 27 · $2.5B mcap · 28M float · 1.91% daily turnover · Short 56% of daily vol
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.5B
52W Range40-99.5
Volume684,522
Avg Volume526,081
Beta2.05
Dividend—
Analyst Ratings
11 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJohn D. Quisel
Employees165
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-12
321 Arsenal Street
Watertown, MA 02472
US
617 674 9274
About Disc Medicine, Inc.

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Recent Insider Trades

NameTypeSharesPriceDate
Bitterman Kevin M-Exempt 7,136 $45.69 2026-09-11
Bitterman Kevin M-Exempt 10,000 $38.85 2026-09-11
Bitterman Kevin M-Exempt 10,000 $50.86 2026-09-11
Bitterman Kevin S-Sale 27,136 $70.11 2026-09-11
Bitterman Kevin M-Exempt 7,136 $45.69 2026-09-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms